203 related articles for article (PubMed ID: 29784844)
1. Incidences of Pseudomonas aeruginosa-Associated Ventilator-Associated Pneumonia within Studies of Respiratory Tract Applications of Polymyxin: Testing the Stoutenbeek Concurrency Postulates.
Hurley JC
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784844
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical Acinetobacter-associated ventilator-associated pneumonia incidence rates within prevention studies using respiratory tract applications of topical polymyxin: benchmarking the evidence base.
Hurley JC
J Hosp Infect; 2018 Sep; 100(1):105-113. PubMed ID: 29649555
[TBL] [Abstract][Full Text] [Related]
3. Lack of impact of selective digestive decontamination on Pseudomonas aeruginosa ventilator-associated pneumonia: benchmarking the evidence base.
Hurley JC
J Antimicrob Chemother; 2011 Jun; 66(6):1365-73. PubMed ID: 21429939
[TBL] [Abstract][Full Text] [Related]
4. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
5. Unusually High Incidences of Staphylococcus aureus Infection within Studies of Ventilator Associated Pneumonia Prevention Using Topical Antibiotics: Benchmarking the Evidence Base.
Hurley JC
Microorganisms; 2018 Jan; 6(1):. PubMed ID: 29300363
[TBL] [Abstract][Full Text] [Related]
6. Unusually High Incidences of
Hurley JC
Open Forum Infect Dis; 2018 Nov; 5(11):ofy256. PubMed ID: 30465011
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical ventilator associated pneumonia incidences among selective digestive decontamination studies versus other studies of mechanically ventilated patients: benchmarking the evidence base.
Hurley JC
Crit Care; 2011; 15(1):R7. PubMed ID: 21214897
[TBL] [Abstract][Full Text] [Related]
8. Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patients.
Klick JM; du Moulin GC; Hedley-Whyte J; Teres D; Bushnell LS; Feingold DS
J Clin Invest; 1975 Mar; 55(3):514-9. PubMed ID: 163848
[TBL] [Abstract][Full Text] [Related]
9. The perfidious effect of topical placebo: calibration of Staphylococcus aureus ventilator-associated pneumonia incidence within selective digestive decontamination studies versus the broader evidence base.
Hurley JC
Antimicrob Agents Chemother; 2013 Sep; 57(9):4524-31. PubMed ID: 23836178
[TBL] [Abstract][Full Text] [Related]
10. Topical antibiotics as a major contextual hazard toward bacteremia within selective digestive decontamination studies: a meta-analysis.
Hurley JC
BMC Infect Dis; 2014 Dec; 14():714. PubMed ID: 25551776
[TBL] [Abstract][Full Text] [Related]
11. Prevention of gram-negative bacillary pneumonia using aerosol polymyxin as prophylaxis. I. Effect on the colonization pattern of the upper respiratory tract of seriously ill patients.
Greenfield S; Teres D; Bushnell LS; Hedley-Whyte J; Feingold DS
J Clin Invest; 1973 Nov; 52(11):2935-40. PubMed ID: 4356004
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin to prevent Pseudomonas aeruginosa ventilator-associated pneumonia by inhibition of quorum sensing: a randomized controlled trial.
van Delden C; Köhler T; Brunner-Ferber F; François B; Carlet J; Pechère JC
Intensive Care Med; 2012 Jul; 38(7):1118-25. PubMed ID: 22527075
[TBL] [Abstract][Full Text] [Related]
13. Ventilator-associated pneumonia prevention methods using topical antibiotics: herd protection or herd peril?
Hurley JC
Chest; 2014 Oct; 146(4):890-898. PubMed ID: 25287997
[TBL] [Abstract][Full Text] [Related]
14. Effect of antibiotics administered via the respiratory tract in the prevention of ventilator-associated pneumonia: A systematic review and meta-analysis.
Póvoa FCC; Cardinal-Fernandez P; Maia IS; Reboredo MM; Pinheiro BV
J Crit Care; 2018 Feb; 43():240-245. PubMed ID: 28942198
[TBL] [Abstract][Full Text] [Related]
15. ICU-acquired candidemia within selective digestive decontamination studies: a meta-analysis.
Hurley JC
Intensive Care Med; 2015 Nov; 41(11):1877-85. PubMed ID: 26239730
[TBL] [Abstract][Full Text] [Related]
16. Structural equation modeling the "control of gut overgrowth" in the prevention of ICU-acquired Gram-negative infection.
Hurley JC
Crit Care; 2020 May; 24(1):189. PubMed ID: 32366267
[TBL] [Abstract][Full Text] [Related]
17. Impact of selective digestive decontamination on respiratory tract Candida among patients with suspected ventilator-associated pneumonia. A meta-analysis.
Hurley JC
Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1121-35. PubMed ID: 27116009
[TBL] [Abstract][Full Text] [Related]
18. Profound effect of study design factors on ventilator-associated pneumonia incidence of prevention studies: benchmarking the literature experience.
Hurley JC
J Antimicrob Chemother; 2008 May; 61(5):1154-61. PubMed ID: 18326854
[TBL] [Abstract][Full Text] [Related]
19. Aerosolized tobramycin for Pseudomonas aeruginosa ventilator-associated pneumonia in patients with acute respiratory distress syndrome.
Migiyama Y; Hirosako S; Tokunaga K; Migiyama E; Tashiro T; Sagishima K; Kamohara H; Kinoshita Y; Kohrogi H
Pulm Pharmacol Ther; 2017 Aug; 45():142-147. PubMed ID: 28450200
[TBL] [Abstract][Full Text] [Related]
20. Aerosol polymyxin and pneumonia in seriously ill patients.
Feeley TW; Du Moulin GC; Hedley-Whyte J; Bushnell LS; Gilbert JP; Feingold DS
N Engl J Med; 1975 Sep; 293(10):471-5. PubMed ID: 168487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
